Matches in SemOpenAlex for { <https://semopenalex.org/work/W4365483309> ?p ?o ?g. }
- W4365483309 endingPage "1718" @default.
- W4365483309 startingPage "1708" @default.
- W4365483309 abstract "Developing new therapeutics for any of the more than 100 sarcoma subtypes presents a challenge. After progression from standard therapies, patients with sarcoma may be referred for enrollment in early-phase trials. This study aimed to investigate whether enrollment in biomarker-matched early-phase clinical trials leads to better outcomes for patients with advanced sarcoma.In this retrospective analysis, investigational treatment characteristics and longitudinal survival outcomes were analyzed in patients with biopsy-confirmed sarcoma enrolled in early-phase trials at MD Anderson Cancer Center from May 2006 to July 2021.Five hundred eighty-seven patients were included [405 soft tissue, 122 bone, 60 gastrointestinal stromal tumor (GIST); median of three prior lines of therapy]. Most common subtypes were leiomyosarcoma (17.2%), liposarcoma (14.0%), and GIST (10.2%). Molecular testing was available for 511 patients (87.1%); 221 patients (37.6%) were treated in matched trials. Overall response rate was 13.1% matched compared with 4.9% in unmatched (P < 0.001); the clinical benefit rate at 6 months was 43.9% vs. 19.9% (P < 0.001). Progression-free survival was longer for patients in matched trials (median, 5.5 vs. 2.4 months; P < 0.001), and overall survival was also superior for patients in matched trials (median, 21.5 vs. 12.3 months; P < 0.001). The benefit of enrollment in matched trials was maintained when patients with GIST were excluded from the analysis.Enrollment in biomarker-matched early-phase trials is associated with improved outcomes in heavily pretreated patients with metastatic sarcoma. Molecular testing of tumors from patients with advanced sarcoma and enrollment in matched trials is a reasonable therapeutic strategy." @default.
- W4365483309 created "2023-04-15" @default.
- W4365483309 creator A5001104743 @default.
- W4365483309 creator A5005436649 @default.
- W4365483309 creator A5008786567 @default.
- W4365483309 creator A5009886411 @default.
- W4365483309 creator A5011494265 @default.
- W4365483309 creator A5026095888 @default.
- W4365483309 creator A5026480682 @default.
- W4365483309 creator A5032743242 @default.
- W4365483309 creator A5035961942 @default.
- W4365483309 creator A5036987409 @default.
- W4365483309 creator A5043675371 @default.
- W4365483309 creator A5043927389 @default.
- W4365483309 creator A5044840107 @default.
- W4365483309 creator A5045084904 @default.
- W4365483309 creator A5046099119 @default.
- W4365483309 creator A5050445982 @default.
- W4365483309 creator A5054595254 @default.
- W4365483309 creator A5054669436 @default.
- W4365483309 creator A5056906070 @default.
- W4365483309 creator A5058077332 @default.
- W4365483309 creator A5061237827 @default.
- W4365483309 creator A5063272827 @default.
- W4365483309 creator A5065709859 @default.
- W4365483309 creator A5068368047 @default.
- W4365483309 creator A5071747925 @default.
- W4365483309 creator A5078531443 @default.
- W4365483309 creator A5080242644 @default.
- W4365483309 creator A5084349853 @default.
- W4365483309 creator A5086634878 @default.
- W4365483309 creator A5086656974 @default.
- W4365483309 creator A5087234749 @default.
- W4365483309 creator A5089849331 @default.
- W4365483309 creator A5090167515 @default.
- W4365483309 creator A5090510992 @default.
- W4365483309 date "2023-04-14" @default.
- W4365483309 modified "2023-09-30" @default.
- W4365483309 title "Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)" @default.
- W4365483309 cites W1965860757 @default.
- W4365483309 cites W2015015957 @default.
- W4365483309 cites W2057195209 @default.
- W4365483309 cites W2103724490 @default.
- W4365483309 cites W2156702007 @default.
- W4365483309 cites W2161375781 @default.
- W4365483309 cites W2161723491 @default.
- W4365483309 cites W2295993263 @default.
- W4365483309 cites W2313480486 @default.
- W4365483309 cites W2604733575 @default.
- W4365483309 cites W2700576167 @default.
- W4365483309 cites W2750123753 @default.
- W4365483309 cites W2755514319 @default.
- W4365483309 cites W2790254562 @default.
- W4365483309 cites W2800425854 @default.
- W4365483309 cites W2800642986 @default.
- W4365483309 cites W2890773677 @default.
- W4365483309 cites W2896920508 @default.
- W4365483309 cites W2938206352 @default.
- W4365483309 cites W2938634307 @default.
- W4365483309 cites W2942099552 @default.
- W4365483309 cites W3009738007 @default.
- W4365483309 cites W3014115276 @default.
- W4365483309 cites W3035573662 @default.
- W4365483309 cites W3092409743 @default.
- W4365483309 cites W3159964039 @default.
- W4365483309 cites W3165059571 @default.
- W4365483309 cites W3171689169 @default.
- W4365483309 cites W3198507306 @default.
- W4365483309 cites W3203170634 @default.
- W4365483309 cites W4221118602 @default.
- W4365483309 cites W4282940141 @default.
- W4365483309 cites W4315754639 @default.
- W4365483309 doi "https://doi.org/10.1158/1078-0432.ccr-22-3629" @default.
- W4365483309 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37058010" @default.
- W4365483309 hasPublicationYear "2023" @default.
- W4365483309 type Work @default.
- W4365483309 citedByCount "1" @default.
- W4365483309 countsByYear W43654833092023 @default.
- W4365483309 crossrefType "journal-article" @default.
- W4365483309 hasAuthorship W4365483309A5001104743 @default.
- W4365483309 hasAuthorship W4365483309A5005436649 @default.
- W4365483309 hasAuthorship W4365483309A5008786567 @default.
- W4365483309 hasAuthorship W4365483309A5009886411 @default.
- W4365483309 hasAuthorship W4365483309A5011494265 @default.
- W4365483309 hasAuthorship W4365483309A5026095888 @default.
- W4365483309 hasAuthorship W4365483309A5026480682 @default.
- W4365483309 hasAuthorship W4365483309A5032743242 @default.
- W4365483309 hasAuthorship W4365483309A5035961942 @default.
- W4365483309 hasAuthorship W4365483309A5036987409 @default.
- W4365483309 hasAuthorship W4365483309A5043675371 @default.
- W4365483309 hasAuthorship W4365483309A5043927389 @default.
- W4365483309 hasAuthorship W4365483309A5044840107 @default.
- W4365483309 hasAuthorship W4365483309A5045084904 @default.
- W4365483309 hasAuthorship W4365483309A5046099119 @default.
- W4365483309 hasAuthorship W4365483309A5050445982 @default.
- W4365483309 hasAuthorship W4365483309A5054595254 @default.
- W4365483309 hasAuthorship W4365483309A5054669436 @default.
- W4365483309 hasAuthorship W4365483309A5056906070 @default.